Bayer CropScience Limited (BAYERCROP.BO)
INR 5739.05
(0.65%)
INR 5739.05
(0.65%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 9.74 Billion | 6.09 Billion | 2.15 Billion | 6.86 Billion | 6.65 Billion | 4.32 Billion |
| Net Income | 7.4 Billion | 9.9 Billion | 8.46 Billion | 7.94 Billion | 5.83 Billion | 4.8 Billion |
| Depreciation & Amortization | 740 Million | 795 Million | 645 Million | 735 Million | 653 Million | 438 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 339 Million | -1.4 Billion | -4.06 Billion | -74 Million | 281 Million | 902 Million |
| Other non-cash items | 3.21 Billion | -3.19 Billion | -2.89 Billion | -1.73 Billion | -106 Million | -1.81 Billion |
| Investing Cash Flow | -300 Million | 833 Million | 642 Million | 67 Million | -289 Million | -4.14 Billion |
| Investments in PPE | -457 Million | -773 Million | -554 Million | -420 Million | -413 Million | -602 Million |
| Acquisitions | 63 Million | 1.11 Billion | 614 Million | 108 Million | 134 Million | -3.96 Billion |
| Investment purchases | - | 299 Million | 281 Million | -11 Million | -400 Million | -3.96 Billion |
| Sales/Maturities of investments | 17 Million | 104 Million | 231 Million | 289 Million | 81 Million | 72 Million |
| Other Investing Activities | 77 Million | 92 Million | 70 Million | 101 Million | 309 Million | 4.3 Billion |
| Financing Cash Flow | -6.48 Billion | -6.13 Billion | -7.03 Billion | -5.55 Billion | -1.48 Billion | -1.58 Billion |
| Debt repayment | - | - | - | -140 Million | -475 Million | -23.89 Billion |
| Dividends payments | -6.06 Billion | -5.61 Billion | -6.72 Billion | -5.16 Billion | -1.23 Billion | -1.53 Billion |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -496 Million | -521 Million | -305 Million | -258 Million | 7 Million | 23.57 Billion |
| Accounts receivables | 129 Million | 313 Million | -2.56 Billion | -378 Million | -205 Million | 1.71 Billion |
| Accounts payables | -2.68 Billion | 533 Million | -97 Million | 3.55 Billion | -1.69 Billion | 2.5 Billion |
| Inventory | 2.07 Billion | -3.57 Billion | -2.36 Billion | -3.95 Billion | 1.64 Billion | -2.88 Billion |
| Other working capital | 819 Million | 1.32 Billion | 962 Million | 702 Million | 533 Million | -431 Million |
| Cash at beginning of period | 8.68 Billion | 7.8 Billion | 12.04 Billion | 10.66 Billion | 5.78 Billion | 4.16 Billion |
| Cash at end of period | 11.64 Billion | 8.6 Billion | 7.8 Billion | 12.04 Billion | 10.66 Billion | 5.78 Billion |
| Capital Expenditure | -457 Million | -773 Million | -554 Million | -420 Million | -413 Million | -602 Million |
| Effect of forex changes on cash | - | - | - | - | - | 3.01 Billion |
| Net cash flow / Change in cash | 2.96 Billion | 794 Million | -4.23 Billion | 1.37 Billion | 4.88 Billion | 1.61 Billion |
| Free Cash Flow | 9.28 Billion | 5.32 Billion | 1.6 Billion | 6.44 Billion | 6.24 Billion | 3.72 Billion |
| Breakdown | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 7.4 Billion | 931 Million | 2.22 Billion | 3.28 Billion | 9.9 Billion | 1.58 Billion |
| Depreciation & Amortization | 740 Million | 152 Million | 116 Million | 313 Million | 795 Million | 271 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 339 Million | - | - | - | -1.4 Billion | - |
| Other non-cash items | 3.21 Billion | -152 Million | -116 Million | -313 Million | -3.19 Billion | -271 Million |
| Investing Cash Flow | -300 Million | - | - | - | 833 Million | - |
| Investments in PPE | -457 Million | - | - | - | -773 Million | - |
| Acquisitions | 63 Million | - | - | - | 1.11 Billion | - |
| Investment purchases | - | - | - | - | 299 Million | - |
| Sales/Maturities of investments | 17 Million | - | - | - | 104 Million | - |
| Other Investing Activities | 77 Million | - | - | - | 92 Million | - |
| Financing Cash Flow | -6.48 Billion | - | - | - | -6.13 Billion | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | -6.06 Billion | - | - | - | -5.61 Billion | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | -521 Million | - |
| Accounts receivables | 129 Million | - | - | - | 313 Million | - |
| Accounts payables | -2.68 Billion | - | - | - | 533 Million | - |
| Inventory | 2.07 Billion | - | - | - | -3.57 Billion | - |
| Other working capital | 819 Million | - | - | - | 1.32 Billion | - |
| Cash at beginning of period | 8.68 Billion | 5.11 Billion | 2.88 Billion | 8.68 Billion | 7.8 Billion | 7.09 Billion |
| Cash at end of period | 11.64 Billion | 931 Million | 5.11 Billion | 3.28 Billion | 8.6 Billion | 8.68 Billion |
| Capital Expenditure | -457 Million | - | - | - | -773 Million | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 2.96 Billion | -4.18 Billion | 2.22 Billion | -5.39 Billion | 794 Million | 1.58 Billion |
| Free Cash Flow | 9.28 Billion | 931 Million | 2.22 Billion | 3.28 Billion | 5.32 Billion | 1.58 Billion |
000550
SILVERTUC
MPU
VNO-PO
GMET
HESTERBIO